Literature DB >> 31473764

Consequences of Slow Progress Toward Pragmatism in Randomized Clinical Trials: It Is Time to Get Practical.

Fatima Rodriguez1,2,3, Robert M Califf4,5, Robert A Harrington1,2,3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31473764      PMCID： PMC9273126          DOI： 10.1001/jamacardio.2019.3922

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   30.154


× No keyword cloud information.
  12 in total

1.  The PRECIS-2 tool: designing trials that are fit for purpose.

Authors:  Kirsty Loudon; Shaun Treweek; Frank Sullivan; Peter Donnan; Kevin E Thorpe; Merrick Zwarenstein
Journal:  BMJ       Date:  2015-05-08

2.  A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.

Authors:  Kevin E Thorpe; Merrick Zwarenstein; Andrew D Oxman; Shaun Treweek; Curt D Furberg; Douglas G Altman; Sean Tunis; Eduardo Bergel; Ian Harvey; David J Magid; Kalipso Chalkidou
Journal:  J Clin Epidemiol       Date:  2009-05       Impact factor: 6.437

Review 3.  The Clinical Trials Transformation Initiative (CTTI).

Authors:  Alberto Grignolo
Journal:  Ann Ist Super Sanita       Date:  2011       Impact factor: 1.663

4.  Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018.

Authors:  Alexander C Fanaroff; Robert M Califf; Stephan Windecker; Sidney C Smith; Renato D Lopes
Journal:  JAMA       Date:  2019-03-19       Impact factor: 56.272

5.  Call to Action: Urgent Challenges in Cardiovascular Disease: A Presidential Advisory From the American Heart Association.

Authors:  Mark McClellan; Nancy Brown; Robert M Califf; John J Warner
Journal:  Circulation       Date:  2019-02-26       Impact factor: 29.690

6.  Feasibility of Obtaining Measures of Lifestyle From a Smartphone App: The MyHeart Counts Cardiovascular Health Study.

Authors:  Michael V McConnell; Anna Shcherbina; Aleksandra Pavlovic; Julian R Homburger; Rachel L Goldfeder; Daryl Waggot; Mildred K Cho; Mary E Rosenberger; William L Haskell; Jonathan Myers; Mary Ann Champagne; Emmanuel Mignot; Martin Landray; Lionel Tarassenko; Robert A Harrington; Alan C Yeung; Euan A Ashley
Journal:  JAMA Cardiol       Date:  2017-01-01       Impact factor: 14.676

7.  Randomization-There Is No Substitute.

Authors:  Gregg C Fonarow
Journal:  JAMA Cardiol       Date:  2016-09-01       Impact factor: 14.676

Review 8.  Trends in the Explanatory or Pragmatic Nature of Cardiovascular Clinical Trials Over 2 Decades.

Authors:  Nariman Sepehrvand; Wendimagegn Alemayehu; Debraj Das; Arjun K Gupta; Pishoy Gouda; Anukul Ghimire; Amy X Du; Sanaz Hatami; Hazal E Babadagli; Sanam Verma; Zakariya Kashour; Justin A Ezekowitz
Journal:  JAMA Cardiol       Date:  2019-11-01       Impact factor: 14.676

9.  Exploring the ethical and regulatory issues in pragmatic clinical trials.

Authors:  Robert M Califf; Jeremy Sugarman
Journal:  Clin Trials       Date:  2015-09-15       Impact factor: 2.486

Review 10.  The ADAPTABLE Trial and Aspirin Dosing in Secondary Prevention for Patients with Coronary Artery Disease.

Authors:  Abigail Johnston; W Schuyler Jones; Adrian F Hernandez
Journal:  Curr Cardiol Rep       Date:  2016-08       Impact factor: 2.931
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.